(Press-News.org) KEY TAKEAWAYS:
Adding IL-12, a cytokine produced by various immune cells, to mRNA vaccines improves T cell responses
This could make the benefits of vaccines last longer
This is also a promising approach for reducing the risk of cancer
In the quest to design vaccines that better help the body’s immune system fight disease, scientists are always looking for more tools for their arsenal. The strong antibody responses generated by vaccines provide an important first round of defense, but “you always want to have a backup plan,” says Biomedical Graduate Studies Ph.D. student Emily A. Aunins, considering viruses mutate to evade antibody responses that become widespread in a population. T cells, however, vary more between people and can still respond to reinfection and mutated viruses.
But scientists also continue to seek ways to improve T cell responses so the benefits of vaccines last longer. One avenue is adjuvants, substances that increase the efficacy of treatments. In a new study, researchers from the School of Veterinary Medicine, Perelman School of Medicine, and Children’s Hospital of Philadelphia tested the effects of adding interleukin-12 (IL-12)—a cytokine, or type of protein, that is produced by various immune cells—to vaccines in mice.
They found that this enhanced responses from CD8+ T cells—white blood cells that aid in the body’s immune response by killing harmful cells—against SARS-CoV-2 and influenza, and that it improved protection against melanoma and listeria infection. Their findings are published in Science Immunology.
IL-12 is naturally produced by the body in response to many infections, and researchers have utilized IL-12 as a vaccine adjuvant to promote immunity against parasitic, viral, and bacterial infections.
Designing vaccines that induce strong responses from CD8+ T cells has historically been a challenge. But mRNA vaccines changed the game, says Penn Vet professor Christopher A. Hunter, senior author on the paper. Data from the last four years show that people who generate strong T cell responses from the mRNA-based COVID vaccines are less likely to get breakthrough infections or become hospitalized if they do.
One practical aspect of an IL-12 mRNA vaccine “is being able to reduce the frequency and amount of vaccine. Anything that can be used to reduce injection frequency and dose-related adverse events is a good thing, and so this allows us to think about that as a strategy,” says Anthony T. Phan, a research associate in Hunter’s laboratory and co-lead author with Aunins. Phan adds that the team’s findings about cytokine biology could inform therapeutics for tumors as well as targeted vaccines that provide protection of the gut or lungs.
“Cytokine mRNA is clearly a promising and clever approach to enhance immune stimulation against cancer and pre-cancer lesions,” says Susan M. Domchek, director of the Abramson Cancer Center’s Basser Cancer Interception Institute, which provided funding for the study. “We are hopeful this technology can move as fast as possible into the clinic for patients and individuals at risk of cancer.”
Hunter says the study came together through his lab’s interest in cytokine biology and Phan’s particular interest in CD8+ T cells; the work of Drew Weissman, 2023 Nobel laureate and director of the Penn Institute for RNA Innovation, on vaccine development; and the expertise of Penn Medicine assistant professor Mohamad-Gabriel Alameh in nanoparticle design, production, and development of vaccines against bacterial pathogens.
“This is why you’re at a university, so you can meet people that you don’t usually interact with, and you find common interests,” Hunter says. Alameh, who met Hunter and Phan on campus, says he quickly realized that combining cytokine-based immune modulation and material engineering is the best route to tailor vaccine responses.
The support from the National Institutes of Health’s Adjuvant Discovery Program also made this work possible.
The paper also “paves the way to explore rationally designed mRNA vaccine adjuvants moving forward, capitalizing on decades of cytokine biology research,” Aunins says. For example, this team continues to work on the impact of other cytokine mRNAs that might can be used to modulate the immune response. Additionally, Phan says Weissman is interested in understanding whether IL-12 could improve vaccine candidates for HIV, while ongoing research with Scott Hensley from Penn Medicine is focused on the ability to deploy this approach across species for avian influenza.
Emily Aunins is a fourth-year Ph.D. student in cell and molecular biology: microbiology, virology, and parasitology.
Christopher A. Hunter is the Mindy Halikman Heyer Distinguished Professor of Pathobiology at the University of Pennsylvania School of Veterinary Medicine.
Anthony Phan is a research associate in Hunter’s lab.
Drew Weissman is the Roberts Family Professor in Vaccine Research, director of vaccine research in the Division of Infectious Diseases, and director of the Penn Institute for RNA Innovation in the Perelman School of Medicine.
Mohamad-Gabriel Alameh is an assistant professor of pathology and laboratory medicine in the Perelman School of Medicine and Children’s Hospital, and co-director of the mRNA Core at the Penn Institute for RNA Innovation.
Other co-authors include Molly E. Bunkofske, David A. Christian, Elisa Cruz-Morales, Maria Merolle, Phillip Scott, Keenan M. O’Dea, and Anabel Zabal Peñafiel of Penn Vet; Garima Dwivdedi, Colleen Furey, Scott E. Hensley, and Robert H. Vonderheide of Penn Medicine; Ying Tam of Acuitas Therapeutics; and Ross M. Kedl of the University of Colorado Anschutz School of Medicine.
This research was supported by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (UO1 AI160664, UO1 AI157247, RO1 AI 189513, U19-AI142596, U19-AI142596, UM1-AI144371, 75N93019C000550, P01AI158571, 75N93021C00015, and R01AI08686, T32 AI007632, and T32 CA009140), the Basser Cancer Interception Institute at the University of Pennsylvania, the Commonwealth of Pennsylvania, and the Abramson Cancer Center NCI Grant (P30 016520).
END
Improving T cell responses to vaccines
Penn Vet and Penn Medicine researchers have modified mRNA vaccines to include the cytokine IL-12 and improve T cell responses which could improve the body’s ability to fight infections
2025-06-06
ELSE PRESS RELEASES FROM THIS DATE:
Nurses speak out: fixing care for disadvantaged patients
2025-06-06
PHILADELPHIA (June 6, 2025) – A new Penn Nursing Center for Health Outcomes & Policy Research (CHOPR) study sheds light on the critical factors that help or hinder hospital nurses in providing quality care to socially disadvantaged populations. The findings, published in JAMA Network Open, offer vital insights to inform hospital strategies for advancing high-quality, equitable care.
The study, which analyzed open-text responses from 1084 direct care hospital nurses across 58 New York and Illinois hospitals, identified six key themes impacting care delivery:
Profits ...
Fecal transplants: Promising treatment or potential health risk?
2025-06-06
Fecal microbiota transplants (FMT) have been touted as a potential treatment for a variety of conditions, from inflammatory bowel diseases, obesity, and type 2 diabetes to autism. New research from the University of Chicago, however, cautions against widespread use of FMT because of the potential for long-lasting, unintended health consequences for recipients.
FMT involves transferring microbes in the stool from a healthy person to a sick one, in hopes of restoring a healthy equilibrium in the gut microbiome. Since stools contain primarily anaerobic microbes from the colon (i.e. they can’t tolerate oxygen), FMT can cause mismatches in the gut ecosystem when those bacteria colonize the ...
US workers’ self-reported mental health outcomes by industry and occupation
2025-06-06
About The Study: In this cross-sectional study, poor mental health among workers varied significantly by sociodemographic categories; significant differences among industry and occupation groups remained after adjustment. More research is needed on the effects of work-related factors on mental health, which may inform tailored treatment and prevention strategies.
Corresponding Author: To contact the corresponding author, Aaron L. Sussell, PhD, email als7@cdc.gov.
To access the embargoed study: ...
Support for care economy policies by political affiliation and caregiving responsibilities
2025-06-06
About The Study: The results of this cohort study suggest that, despite some differences by political affiliation, there is high support of policies to support the adult care economy, suggesting a policy window to advance legislation and executive action to address the care needs of aging populations and populations with disabilities.
Corresponding Author: To contact the corresponding author, Katherine E. M. Miller, PhD, email kmill177@jh.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamahealthforum.2025.1204)
Editor’s ...
Mailed self-collection HPV tests boost cervical cancer screening rates
2025-06-06
Real-world study found self-collection tests were effective at increasing cervical cancer screening participation in underserved U.S. populations
Women who received the self-collection kits were more than twice as likely to participate in screening compared to those who received only a telephone reminder
These results could inform cervical cancer screening health policy
HOUSTON, JUNE 6, 2025 ― Mail-in self-collection tests for human papillomavirus (HPV) more than doubled cervical cancer screening participation among never- and under-screened ...
AMS announces 1,000 broadcast meteorologists certified
2025-06-06
The American Meteorological Society (AMS) today announced it has awarded its 1,000th AMS Certified Broadcast Meteorologist (CBM) designation. Since 2005, on-air meteorologists have displayed the AMS CBM seal to denote their expertise not only in weather-related communication but also in meteorological science and forecasting.
“The CBM indicates that your weather broadcaster is a scientist who understands meteorology and forecasting, and who has achieved our standard of excellence in communicating technically sound knowledge to the public in a clear and responsible manner,” says Kelly Savoie, Director of Career Development ...
Many Americans unaware high blood pressure usually has no noticeable symptoms
2025-06-06
Hypertension or high blood pressure, which can lead to heart attack and stroke, the two top causes of death in the United States, is one of the most widespread chronic illnesses in America, afflicting nearly half of adults. In a recent Annenberg Public Policy Center (APPC) health survey, 35% of respondents report having been diagnosed with high blood pressure and two-thirds of this group say they’re somewhat or very worried about having high blood pressure.
But the survey finds that ...
IEEE study describes polymer waveguides for reliable, high-capacity optical communication
2025-06-06
Co-packaged optics (CPO) technology can integrate photonic integrated circuits (PICs) with electronic integrated circuits (EICs) like CPUs and GPUs on a single platform. This advanced technology has immense potential to improve data transmission efficiency within data centers and high-performance computing environments. CPO systems require a laser source for operation, which can be either integrated directly into the silicon photonic chips (integrated laser sources) or provided externally. While integrated laser sources allow for dense CPO integration, ensuring ...
Motor protein myosin XI is crucial for active boron uptake in plants
2025-06-06
Boron, though required only in minimal amounts, is vital for plant development. It strengthens cell walls and supports the growth of roots and shoots. Normally, boron, in the form of boric acid, is passively absorbed by plant roots and transported throughout the plant via diffusion. However, boron is often scarce in soil, particularly in arid regions, making passive absorption impossible. To combat this, plants have evolved proteins that actively transport boron from the soil into the plant. In Arabidopsis thaliana, the protein AtNIP5;1—a boric acid channel ...
Ultra-selective aptamers give viruses a taste of their own medicine
2025-06-06
We have all heard of antibodies – proteins produced by our bodies to bind to viruses or bacteria, marking them for elimination by the immune system. But not all of us are familiar with aptamers: short segments of DNA or RNA that are designed to bind, like antibodies, to specific targets. Synthetic and inexpensive to produce, aptamers are attractive alternatives to antibodies for biomedical diagnostics and therapeutics.
When new aptamer binders are needed, for example to detect a new virus, they are developed from libraries of millions of nucleic acid sequences from which the best matches for a given target are selected and amplified. ...
LAST 30 PRESS RELEASES:
Fentanyl detection through packaging
Prof. Eran Meshorer elected to EMBO for pioneering work in epigenetics
New 3D glacier visualizations provide insights into a hotter Earth
Creativity across disciplines
Consequences of low Antarctic sea ice
Hear here: How loudness and acoustic cues help us judge where a speaker is facing
A unique method of rare-earth recycling can strengthen the raw material independence of Europe and America
Epilepsy self-management program shows promise to control seizures, improve mood and quality of life
Fat may play an important role in brain metabolism
New study finds no lasting impact of pandemic pet ownership on human well-being
New insights on genetic damage of some chemotherapies could guide future treatments with less harmful side effects
Gut microbes could protect us from toxic ‘forever chemicals’
Novel modelling links sea ice loss to Antarctic ice shelf calving events
Scientists can tell how fast you're aging from a single brain scan
U.S. uterine cancer incidence and mortality rates expected to significantly increase by 2050
Public take the lead in discovery of new exploding star
What are they vaping? Study reveals alarming surge in adolescent vaping of THC, CBD, and synthetic cannabinoids
ECMWF - delivering forecasts over 10 times faster and cutting energy usage by 1000
Brazilian neuroscientist reveals how viral infections transform the brain through microscopic detective work
Turning social fragmentation into action through discovering relatedness
Cheese may really be giving you nightmares, scientists find
Study reveals most common medical emergencies in schools
Breathable yet protective: Next-gen medical textiles with micro/nano networks
Frequency-engineered MXene supercapacitors enable efficient pulse charging in TENG–SC hybrid systems
Developed an AI-based classification system for facial pigmented lesions
Achieving 20% efficiency in halogen-free organic solar cells via isomeric additive-mediated sequential processing
New book Terraglossia reclaims language, Country and culture
The most effective diabetes drugs don't reach enough patients yet
Breast cancer risk in younger women may be influenced by hormone therapy
Strategies for staying smoke-free after rehab
[Press-News.org] Improving T cell responses to vaccinesPenn Vet and Penn Medicine researchers have modified mRNA vaccines to include the cytokine IL-12 and improve T cell responses which could improve the body’s ability to fight infections